Search
Descriptor English: Papillomavirus Vaccines
Descriptor Spanish: Vacunas contra Papillomavirus
Descriptor vacunas para papilomavirus
Entry term(s) vacuna contra el VPH
vacuna contra el papilomavirus humano
vacuna contra el virus del papiloma
vacuna contra el virus del papiloma humano
vacunas antipapilomavirus humano
vacunas contra HPV
vacunas contra el HPV
vacunas contra el VPH
vacunas contra el papilomavirus humano
vacunas del papilomavirus humano
vacunas para papilomavirus humano
Scope note: Vacunas o candidatos a vacunas que se utilizan para prevenir las INFECCIONES POR PAPILOMAVIRUS. Las vacunas humanas se dirigen a reducir la incidencia de NEOPLASIAS DEL CUELLO UTERINO, por lo que en ocasiones se las ha considerdo VACUNAS CONTRA EL CANCER. Suelen estar compuestas de PROTEÍNAS DE LA CÁPSIDA, especialmente la proteína L1, obtenidas de diversos tipos de ALFAPAPILOMAVIRUS.
Descriptor Portuguese: Vacinas contra Papillomavirus
Descriptor French: Vaccins contre les papillomavirus
Entry term(s): HPV Vaccine
HPV Vaccines
Human Papilloma Virus Vaccine
Human Papilloma Virus Vaccines
Human Papillomavirus Vaccine
Human Papillomavirus Vaccines
Papillomavirus Vaccine
Papillomavirus Vaccine, Human
Papillomavirus Vaccines, Human
Vaccine, HPV
Vaccine, Human Papillomavirus
Vaccine, Papillomavirus
Vaccines, Human Papillomavirus
Vaccines, Papillomavirus
Tree number(s): D20.215.894.899.498
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D053918
Scope note: Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Previous Indexing: Cancer Vaccines (1996-2006)
Viral Vaccines (1989-2006)
Public MeSH Note: 2007
History Note: 2007
Related: Cancer Vaccines MeSH
DeCS ID: 52407
Unique ID: D053918
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2007/01/01
Date of Entry: 2006/07/05
Revision Date: 2020/05/27
Papillomavirus Vaccines - Preferred
Concept UI M0498157
Scope note Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
Preferred term Papillomavirus Vaccines
Entry term(s) Papillomavirus Vaccine
Vaccine, Papillomavirus
Vaccines, Papillomavirus
Human Papillomavirus Vaccines - Narrower
Concept UI M0498131
Preferred term Human Papillomavirus Vaccines
Entry term(s) HPV Vaccine
HPV Vaccines
Human Papilloma Virus Vaccine
Human Papilloma Virus Vaccines
Human Papillomavirus Vaccine
Papillomavirus Vaccine, Human
Papillomavirus Vaccines, Human
Vaccine, HPV
Vaccine, Human Papillomavirus
Vaccines, Human Papillomavirus



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey